Nurotron Biotechnology Co., Ltd.
PrivateLast Round
Strategic
May 15, 2025
Est. Valuation
$378.8M
Total Funding Raised
$17M
Company Overview
Nurotron Biotechnology Co., Ltd. is a medical device company that designs, develops, and manufactures neurostimulation systems, including cochlear implants, auditory brainstem implants, and other neural electrical stimulation rehabilitation products.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nurotron Biotechnology Co., Ltd. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nurotron Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 15, 2025 | ||||
| Strategic | May 16, 2024 | ||||
| VC Round | Jun 1, 2023 | ||||
| VC Round | Feb 1, 2021 | ||||
| Strategic | Sep 29, 2020 | ||||
Early Funding | Aug 1, 2019 |
Nurotron Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Strategic |
| Zhejiang Sino Wisdom Investment Management | Series B Extension |
| Chenghe Capital Management | Private Equity, VC Round |
| 德同资本 | Series C |
| Yinrun Capital | Early Funding |
| Tianyi Group | Series B Extension |
| Zhejiang Jiuren Capital Management Co., Ltd. | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2020
Closed a strategic round with a post-money valuation of $367.11M.
- Aug 1, 2019
Secured funding from Yinrun Capital and Beili Venture Capital.
Nurotron Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nurotron Biotechnology Co., Ltd.'s valuation, stock price, and market status.